{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:59:29Z","timestamp":1772503169112,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11695-023-06911-w","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T07:01:52Z","timestamp":1699081312000},"page":"4017-4025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum Versus Fecal Calprotectin Levels in Patients with Severe Obesity Before and 6 Months After Roux-Y-Gastric Bypass: Report of the Prospective Leaky-Gut Study"],"prefix":"10.1007","volume":"33","author":[{"given":"Ella","family":"Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Trystram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Fellahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedi A.","family":"Soula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Thenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Oppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Poitou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-7813","authenticated-orcid":false,"given":"Laurent","family":"Genser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"6911_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0140-6736(18)32822-8","volume":"393","author":"BA Swinburn","year":"2019","unstructured":"Swinburn BA, Kraak VI, Allender S, et al. The Global Syndemic of Obesity, Undernutrition, and climate change: the Lancet commission report. Lancet. 2019;393:791\u2013846.","journal-title":"Lancet."},{"key":"6911_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/jcm12030925","volume":"12","author":"A Fontbonne","year":"2023","unstructured":"Fontbonne A, Currie A, Tounian P,\u00a0 et al. Prevalence of overweight and obesity in France: the 2020 Obepi-Roche study by the \u201cLigue Contre l\u2019Ob\u00e9sit\u00e9.\u201d. J Clin Med. 2023;12:925.","journal-title":"J Clin Med."},{"key":"6911_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3945\/ajcn.111.013771","volume":"94","author":"E Dalmas","year":"2011","unstructured":"Dalmas E, Rouault C, Abdennour M,\u00a0 et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94:450\u20138.","journal-title":"Am J Clin Nutr."},{"key":"6911_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N,\u00a0 et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56:1751\u20139.","journal-title":"Hepatology."},{"key":"6911_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","volume":"84","author":"G Marcelin","year":"2022","unstructured":"Marcelin G, Gautier EL, Cl\u00e9ment K. Adipose tissue fibrosis in obesity: etiology and challenges. Annu Rev Physiol. 2022;84:135\u201355.","journal-title":"Annu Rev Physiol."},{"key":"6911_CR6","doi-asserted-by":"crossref","unstructured":"Monteiro-Sepulveda M, Touch S, Mendes-S\u00e1 C,\u00a0 et al. Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling. Cell Metab. 2015;","DOI":"10.1016\/j.cmet.2015.05.020"},{"key":"6911_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/path.5134","volume":"246","author":"L Genser","year":"2018","unstructured":"Genser L, Aguanno D, Soula HA,\u00a0 et al. Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes. J Pathol. 2018;246:217\u201330.","journal-title":"J Pathol."},{"key":"6911_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4291\/wjgp.v6.i4.203","volume":"6","author":"JM Ben\u00edtez","year":"2015","unstructured":"Ben\u00edtez JM, Garc\u00eda-S\u00e1nchez V. Faecal calprotectin: management in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6:203\u20139.","journal-title":"World J Gastrointest Pathophysiol."},{"key":"6911_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1586\/17474124.2014.869476","volume":"8","author":"E Burri","year":"2014","unstructured":"Burri E, Beglinger C. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:197\u2013210.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"6911_CR10","doi-asserted-by":"publisher","first-page":"e0216528","DOI":"10.1371\/journal.pone.0216528","volume":"14","author":"KA Murray","year":"2019","unstructured":"Murray KA, Hoad CL, Garratt J, et al. A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis. PLoS One. 2019;14:e0216528.","journal-title":"PLoS One."},{"key":"6911_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajg.2020.09.003","volume":"21","author":"F Demirba\u015f","year":"2020","unstructured":"Demirba\u015f F, \u00c7altepe G, Comba A,\u00a0 et al. Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children. Arab J Gastroenterol. 2020;21:211\u20135.","journal-title":"Arab J Gastroenterol."},{"key":"6911_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41366-019-0492-z","volume":"44","author":"J Wilbrink","year":"2020","unstructured":"Wilbrink J, Bernards N, Mujagic Z,\u00a0 et al. Intestinal barrier function in morbid obesity: results of a prospective study on the effect of sleeve gastrectomy. Int J Obes (Lond). 2020;44:368\u201376.","journal-title":"Int J Obes (Lond)."},{"key":"6911_CR13","doi-asserted-by":"publisher","first-page":"G11","DOI":"10.1152\/ajpgi.00113.2021","volume":"321","author":"B Seethaler","year":"2021","unstructured":"Seethaler B, Basrai M, Neyrinck AM,\u00a0 et al. Biomarkers for assessment of intestinal permeability in clinical practice. Am J Physiol Gastrointest Liver Physiol. 2021;321:G11\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"6911_CR14","first-page":"183","volume":"12","author":"T Azramezani Kopi","year":"2019","unstructured":"Azramezani Kopi T, Shahrokh S, Mirzaei S, et al. The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study. Gastroenterol Hepatol Bed Bench. 2019;12:183\u20139.","journal-title":"Gastroenterol Hepatol Bed Bench."},{"key":"6911_CR15","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/j.crohns.2013.06.008","volume":"7","author":"M-A Meuwis","year":"2013","unstructured":"Meuwis M-A, Vernier-Massouille G, Grimaud JC,\u00a0 et al. Serum calprotectin as a biomarker for Crohn\u2019s disease. J Crohns Colitis. 2013;7:e678\u201383.","journal-title":"J Crohns Colitis."},{"key":"6911_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/EJE-12-0374","volume":"167","author":"FJ Ortega","year":"2012","unstructured":"Ortega FJ, Sabater M, Moreno-Navarrete JM,\u00a0 et al. Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. Eur J Endocrinol. 2012;167:569\u201378.","journal-title":"Eur J Endocrinol."},{"key":"6911_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1471-2261-14-196","volume":"14","author":"L Pedersen","year":"2014","unstructured":"Pedersen L, Nybo M, Poulsen MK, et al. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients. BMC Cardiovasc Disord. 2014;14:196.","journal-title":"BMC Cardiovasc Disord."},{"key":"6911_CR18","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1007\/s11695-016-2222-0","volume":"26","author":"TCC Boerlage","year":"2016","unstructured":"Boerlage TCC, Westerink F, Poland DCW, et al. Fecal calprotectin, elastase, and alpha-1-antitrypsin levels after Roux-en-Y gastric bypass; calprotectin is significantly elevated in the majority of patients. Obes Surg. 2016;26:2974\u201380.","journal-title":"Obes Surg."},{"key":"6911_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.soard.2020.10.021","volume":"17","author":"M-A H\u00e4rma","year":"2021","unstructured":"H\u00e4rma M-A, Adeshara K, Istomin N,\u00a0 et al. Gastrointestinal manifestations after Roux-en-Y gastric bypass surgery in individuals with and without type 2 diabetes. Surg Obes Relat Dis. 2021;17:585\u201394.","journal-title":"Surg Obes Relat Dis."},{"key":"6911_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000514576","volume":"6","author":"F Westerink","year":"2021","unstructured":"Westerink F, Huibregtse I, De Hoog M, Bruin S, Meesters E, Brandjes D, et al. Faecal inflammatory biomarkers and gastrointestinal symptoms after bariatric surgery: a longitudinal study. Inflamm Intest Dis. 2021;6:109\u201316.","journal-title":"Inflamm Intest Dis."},{"key":"6911_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s11695-013-1166-x","volume":"24","author":"KA Carswell","year":"2014","unstructured":"Carswell KA, Vincent RP, Belgaumkar AP, et al. The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg. 2014;24:796\u2013805.","journal-title":"Obes Surg."},{"key":"6911_CR22","unstructured":"HAS, HAdS. Ob\u00e9sit\u00e9 : prise en charge chirurgicale chez l\u2019adulte [Internet]. 2009. Available from: http:\/\/www.has-sante.fr\/portail\/jcms\/c765529\/obesite-prise-en-charge-chirurgicalechez-l-adulte.\u00a0Accessed 30\u00a0Oct 2023."},{"key":"6911_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jviscsurg.2017.01.001","volume":"154","author":"L Genser","year":"2017","unstructured":"Genser L, Torcivia A, Helmy N, et al. Laparoscopic Roux-en-Y gastric bypass with hand-sewn gastro-jejunostomy. J Visc Surg. 2017;154:37\u201345.","journal-title":"J Visc Surg."},{"key":"6911_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11690-017-0585-6","volume":"12","author":"L Genser","year":"2017","unstructured":"Genser L, Danion J, Desbeaux A,\u00a0 et al. Le bypass gastrique Roux-en-Y pr\u00e9-colique avec anastomose gastro-j\u00e9junale lin\u00e9aire post\u00e9rieure\u00a0: technique et astuces. Ob\u00e9sit\u00e9. 2017;12:222\u20136.","journal-title":"Ob\u00e9sit\u00e9."},{"key":"6911_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cmet.2015.03.001","volume":"21","author":"H Luck","year":"2015","unstructured":"Luck H, Tsai S, Chung J,\u00a0 et al. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents. Cell Metab. 2015;21:527\u201342.","journal-title":"Cell Metab."},{"key":"6911_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11892-017-0900-5","volume":"17","author":"S Touch","year":"2017","unstructured":"Touch S, Cl\u00e9ment K, Andr\u00e9 S. T Cell populations and functions are altered in human obesity and type 2 diabetes. Current Diabetes Reports. 2017;17:81.","journal-title":"Current Diabetes Reports."},{"key":"6911_CR27","first-page":"77","volume":"39","author":"WGW Pathirana","year":"2018","unstructured":"Pathirana WGW, Chubb SP, Gillett MJ, et al. Faecal calprotectin. Clin Biochem Rev. 2018;39:77\u201390.","journal-title":"Clin Biochem Rev."},{"key":"6911_CR28","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00384-021-03968-w","volume":"36","author":"CR Rowan","year":"2021","unstructured":"Rowan CR, McManus J, Boland K, et al. Visceral adiposity and inflammatory bowel disease. Int J Colorectal Dis. 2021;36:2305\u201319.","journal-title":"Int J Colorectal Dis."},{"key":"6911_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000492579","volume":"73","author":"V Calcaterra","year":"2018","unstructured":"Calcaterra V, De Amici M, Leonard MM,\u00a0 et al. Serum calprotectin level in children: marker of obesity and its metabolic complications. Ann Nutr Metab. 2018;73:177\u201383.","journal-title":"Ann Nutr Metab."},{"key":"6911_CR30","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.3390\/ijerph17207575","volume":"17","author":"G Rowicka","year":"2020","unstructured":"Rowicka G, Dyl\u0105g H, Che\u0142chowska M, et al. Serum calprotectin and chemerin concentrations as markers of low-grade inflammation in prepubertal children with obesity. Int J Environ Res Public Health. 2020;17:7575.","journal-title":"Int J Environ Res Public Health."},{"key":"6911_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/jcm9030857","volume":"9","author":"A Grand","year":"2020","unstructured":"Grand A, Rochette E, Dutheil F,\u00a0 et al. Body mass index and calprotectin blood level correlation in healthy children: an individual patient data meta-analysis. J Clin Med. 2020;9:857.","journal-title":"J Clin Med."},{"key":"6911_CR32","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3945\/ajcn.110.004564","volume":"92","author":"MB Zimmermann","year":"2010","unstructured":"Zimmermann MB, Chassard C, Rohner F,\u00a0 et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d\u2019Ivoire. Am J Clin Nutr. 2010;92:1406\u201315.","journal-title":"Am J Clin Nutr."},{"key":"6911_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13679-019-00351-3","volume":"8","author":"J Deb\u00e9dat","year":"2019","unstructured":"Deb\u00e9dat J, Cl\u00e9ment K, Aron-Wisnewsky J. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8:229\u201342.","journal-title":"Curr Obes Rep."},{"key":"6911_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/nutrit\/nuy064","volume":"77","author":"M Le Gall","year":"2019","unstructured":"Le Gall M, Thenet S, Aguanno D,\u00a0 et al. Intestinal plasticity in response to nutrition and gastrointestinal surgery. Nutr Rev. 2019;77:129\u201343.","journal-title":"Nutr Rev."},{"key":"6911_CR35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11695-016-2343-5","volume":"27","author":"J-M Sabate","year":"2017","unstructured":"Sabate J-M, Coupaye M, Ledoux S,\u00a0 et al. Consequences of small intestinal bacterial overgrowth in obese patients before and after bariatric surgery. Obes Surg. 2017;27:599\u2013605.","journal-title":"Obes Surg."},{"key":"6911_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00125-004-1654-6","volume":"48","author":"C Poitou","year":"2005","unstructured":"Poitou C, Viguerie N, Cancello R,\u00a0 et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia. 2005;48:519\u201328.","journal-title":"Diabetologia."},{"key":"6911_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.clinbiochem.2017.01.006","volume":"50","author":"RK McCann","year":"2017","unstructured":"McCann RK, Smith K, Gaya DR. A prospective single centre pilot evaluation of a serum calprotectin assay in unselected GI patients. Clin Biochem. 2017;50:533\u20136.","journal-title":"Clin Biochem."},{"key":"6911_CR38","doi-asserted-by":"publisher","first-page":"22001","DOI":"10.1038\/s41598-021-01231-4","volume":"11","author":"H Shokri-Afra","year":"2021","unstructured":"Shokri-Afra H, Alikhani A, Moradipoodeh B, et al. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms. Sci Rep. 2021;11:22001.","journal-title":"Sci Rep."}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06911-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-023-06911-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06911-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T14:45:51Z","timestamp":1701269151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-023-06911-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6911"],"URL":"https:\/\/doi.org\/10.1007\/s11695-023-06911-w","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"21 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki principles and was approved by the local ethics committee (CPP Ile-de-France I) and registered at ClinicalTrials.gov ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}